TTOO - Federal Contract Creating Hype. Above The Trend

T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.

SHORT INTEREST
5.5M 08/30/19

P/E Current
-2.07

P/E Ratio (with extraordinary items)
-2.04

Average Recommendation: OVERWEIGHT

Average Target Price: 3.71